Baijin Life Science Holdings Limited (HKG:1466)
Hong Kong · Delayed Price · Currency is HKD 1.140
+0.020 (1.79%)
Jul 10, 2026, 3:45 PM HKT
HKG:1466 Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 89.3 | 135.56 | 53.68 | 86.88 | 62.65 | |
Revenue Growth (YoY) | -34.12% | 152.54% | -38.22% | 38.68% | 44.60% |
Cost of Revenue | 82.64 | 93.57 | 35.58 | 79.05 | 51.66 |
Gross Profit | 6.67 | 41.99 | 18.1 | 7.83 | 10.99 |
Selling, General & Admin | 57.43 | 37.32 | 28.56 | 16.62 | 15.61 |
Other Operating Expenses | -18.13 | -7.82 | -0.48 | -1.24 | 0.14 |
Operating Expenses | 37.54 | 27.94 | 27.68 | 10.5 | 11.22 |
Operating Income | -30.88 | 14.05 | -9.58 | -2.67 | -0.23 |
Interest Expense | -0.81 | -0.97 | -0.28 | -1.03 | -4.38 |
Interest & Investment Income | 0.65 | 1.6 | 1.32 | 0.22 | 0.01 |
Earnings From Equity Investments | -0.03 | - | - | - | - |
Currency Exchange Gain (Loss) | -0.01 | -0.06 | 0 | -2.98 | -1.11 |
Other Non Operating Income (Expenses) | 0.96 | - | - | 14.91 | -10.26 |
EBT Excluding Unusual Items | -30.11 | 14.62 | -8.53 | 8.45 | -15.97 |
Impairment of Goodwill | -13 | -20 | - | - | - |
Gain (Loss) on Sale of Assets | - | 4.05 | - | - | 0.51 |
Asset Writedown | - | -0.03 | - | - | -0 |
Other Unusual Items | - | - | - | 0.23 | - |
Pretax Income | -43.11 | -1.37 | -8.53 | 8.68 | -15.46 |
Income Tax Expense | -0.44 | -1.28 | 0.02 | - | - |
Earnings From Continuing Operations | -42.67 | -0.09 | -8.55 | 8.68 | -15.46 |
Minority Interest in Earnings | 4.81 | -0.23 | 1.1 | - | - |
Net Income | -37.87 | -0.32 | -7.45 | 8.68 | -15.46 |
Net Income to Common | -37.87 | -0.32 | -7.45 | 8.68 | -15.46 |
Shares Outstanding (Basic) | 843 | 694 | 645 | 603 | 355 |
Shares Outstanding (Diluted) | 906 | 694 | 645 | 603 | 355 |
Shares Change (YoY) | 30.54% | 7.58% | 6.89% | 70.17% | 58.07% |
EPS (Basic) | -0.04 | -0.00 | -0.01 | 0.01 | -0.04 |
EPS (Diluted) | -0.06 | -0.00 | -0.01 | 0.01 | -0.04 |
Free Cash Flow | - | -32.97 | -6.64 | -21.55 | 1.06 |
Free Cash Flow Per Share | - | -0.05 | -0.01 | -0.04 | 0.00 |
Gross Margin | 7.46% | 30.97% | 33.72% | 9.01% | 17.55% |
Operating Margin | -34.57% | 10.36% | -17.85% | -3.08% | -0.36% |
Profit Margin | -42.40% | -0.23% | -13.88% | 9.99% | -24.68% |
Free Cash Flow Margin | - | -24.32% | -12.36% | -24.80% | 1.70% |
EBITDA | -27.21 | 17.71 | -8.91 | -2.48 | -0.04 |
EBITDA Margin | -30.47% | 13.06% | -16.60% | -2.86% | -0.06% |
D&A For EBITDA | 3.66 | 3.66 | 0.67 | 0.19 | 0.19 |
EBIT | -30.88 | 14.05 | -9.58 | -2.67 | -0.23 |
EBIT Margin | -34.57% | 10.36% | -17.85% | -3.08% | -0.36% |